IZİsMet Zengin

İsMet Zengin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


İsMet Zengin has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Very late-onset pacemaker pocket infection presenting as a giant granulomatous mass

    by Oğuz Kağan Şentürk, Berat Uğuz, İsMet Zengin, Tufan Günay, İlKen Uğuz

    Pacemaker-related infections are most commonly observed during the early postoperative period; however, in rare instances, they may present many years after device implantation. We report an unusual case of a giant granulomatous pacemaker pocket infection occurring 10 years after the initial implantation. The patient presented with localized inflammatory signs without systemic manifestations. Following surgical removal of the device and the associated mass, histopathological examination confirmed xanthogranulomatous inflammation. Staphylococcus epidermidis was isolated from tissue cultures. Complete device extraction combined with prolonged antimicrobial therapy resulted in full clinical resolution, followed by successful contralateral re-implantation. This case highlights the importance of maintaining long-term vigilance in patients with cardiac implantable electronic devices.

  • Open Access

    Effects of sarcopenia on in-hospital results and mid-term follow-up in patients with coronary artery disease and COVID-19

    by Merve Erkan, İsmet Zengi̇n

    Objectives: Sarcopenia is associated with atherosclerosis, vascular dysfunction, and poor in-hospital prognosis in the general COVID-19 population. Coronary artery disease (CAD) is also associated with poor prognosis in patients with COVID-19, however, the influencing factors in this association have not yet been fully documented. This study aimed to evaluate the effect of sarcopenia on both in-hospital acute-term and mid-term follow-up clinical results in patients with CAD and COVID-19. Methods: The study population was selected from the general COVID-19 population. It consisted of 50 patients with CAD (group I) and 80 age- and gender-matched patients without CAD (group II). In-hospital acute term endpoints were determined as intensive care unit (ICU) admission, intubation, mortality, and its combination. Mid-term follow-up was also made for three-month. Sarcopenia was assessed by indexed skeletal muscle mass at T12 vertebrae level (T12-SMI) on initial chest computed tomography. Multivariable logistic regression analysis was used to detect independently related factors to endpoints. Results: Group I had more severe COVID-19 disease and a higher rate of hospitalization, ICU admission, intubation as well as mortality compared to group II in acute-term. T12-SMI was lower and sarcopenia was more frequent in group I than in group II. During the three-month mid-term follow-up period, no additional adverse results occurred in both groups. In multivariate regression analysis; sarcopenia was independently related to in-hospital combined endpoint. Conclusions: Sarcopenia is associated with in-hospital combined endpoint in patients with CAD during acute-term of COVID-19. However, it has no effect on three-month mid-term follow-up.

  • Open Access

    Systemic Coagulation Inflammation Index Associated With Bleeding in Acute Coronary Syndrome

    by İ. Zengin, K. Severgün

    Aim. Assessment of the inflammatory component of acute coronary syndrome (ACS) and the degree of activation of the coagulation cascade may provide prognostic information. The systemic coagulation-inflammation index (SCI) assesses both inflammation and the coagulation system, and it has also been found to be associated with clinical outcomes. We investigated the relationship between SCI and in-hospital clinical events (acute kidney injury, cardiogenic shock, life-threatening arrhythmia, bleeding) and mortality. Material and methods. The study included 396 patients aged ≥18 yrs who were hospitalized with a diagnosis of ACS. The SCI was calculated using the formula: platelet count (103 / µl) X fibrinogen (g / l) / white blood cell (WBC) count (103 / µl). Patients were divided into two groups according to whether their SCI score was >100 or Results. The mean age of the patients was 61.4±12.2 years and 78.3 % (n=310) were male. The type of ACS was NSTEMI in 56.1 % (n=222). The responsible vessel was the left anterior descending artery (LAD) in 42.4 % of the patients (n=168). The mean SCI score was 97.5±47.1. WBC, neutrophil, and lymphocyte counts were higher in the SCI 100 group. Bleeding from any cause as an in-hospital complication was significantly higher in patients with SCI >100 (p0.05). Conclusions. Bleeding in ACS patients was significantly more common in the group with SCI >100. Thus, SCI may be a useful parameter for predicting in-hospital bleeding complications in ACS. On the other hand, SCI was not associated with mortality and other in-hospital clinical events.


  • Open Access

    Koroner kusp kaynaklı prematüre ventriküler komplekslerin kateter ablasyonu sonrası ortaya çıkan aort kapak yetmezliği sıklığı

    by İsmet Zengi̇n, Selcuk Kanat

    Aims: There are conflicting results about the effect of radiofrequency catheter ablation (RFA) of aortic cusp premature ventricular complexes (PVCs) on aortic valve regurgitation (AR). We aimed to investigate the effect of aortic valve function and integrity of RFA of coronary cusp PVCs. Methods: This cross-sectional study included 54 patients who underwent RFA of the aortic cusp region within the specified indications. Basal echocardiography was performed at baseline and 3 months after radiofrequency catheter ablation of aortic cusp PVCs. An increase of more than 1 degree in AR was considered significant. Results: The mean age of the patients was 44.6±12.0 years and the male gender ratio was 42.6%. On 24-hour rhythm holter monitoring, the mean VES burden was 21.5%, of which 12.9% were right coronary cusp (RCC), 59.3% left coronary cusp (LCC), and 27.8% RCC-LCC junction. Total procedure time was 136.9±33.2 minutes and RFA time was 14.9±11.4 minutes. When pre- and post-ablation parameters were compared, left ventricular ejection fraction was found to be higher after the procedure than before the procedure (p 0.05). Conclusion: There was no increase in the degree of AR as a procedure-related complication and no significant AR was determined in patients who underwent RFA for PVCs in the aortic cusp region. Therefore, it can be concluded that VES ablations in the aortic cusp region are safe for the development of AR.

  • Open Access

    Investigation of the relationship of frontal QRS-T angle and digoxin use and blood digoxin level

    by İsmet Zengi̇n, Berat Uğuz

    Objectives: Digoxin is an antiarrhythmic drug with a narrow therapeutic range and used in clinical conditions such as heart failure and atrial fibrillation. The planar frontal QRS-T angle reflects the deviations between the depolarization and repolarization of the ventricles, and it has been reported that an increase in this angle is associated with an increase in mortality. In our study, the relationship between frontal QRS-T angle and digoxin use and blood digoxin level was investigated. Methods: The study included 105 digoxin users who used digoxin, whose levels were measured, who had an electrocardiogram (ECG) on the system, and 15 patients with similar characteristics, who had an ECG and did not use digoxin. Patients using digoxin and whose levels were measured were also divided into three groups as < 0.8 ng/mL, 0.8-1.2 ng/mL, and > 1.2 ng/mL. The absolute value of the value obtained by subtracting the axis of the T wave from the axis of the QRS angle indicated on the paper, calculated automatically on the 12-lead ECG, was accepted as the frontal QRS-T angle value. Results: Planar frontal QRS-T angle measured by 12-lead ECG in digoxin users was 120º (55.5º-155.5º), while it was 106º (32º-163º) in non-users, and there was no statistical difference between the two groups (p = 0.833). In the evaluation made according to different blood drug levels as < 0.8 ng/mL, 0.8-1.2 ng/mL, > 1.2 ng/mL in digoxin users, no significant difference was observed between the frontal QRS-T angle between the groups (109.5° [60.25°-154.25°] for < 0.8 ng/mL, 136.5° [48.5°-158.5°] for 0.8-1.2 ng/mL, 117° [34°-154°] for 1.2 ng/mL) (p = 0.773).Conclusions: There was no significant difference in frontal QRS-T angle between digoxin users and non-users. There was no significant relationship between different blood digoxin levels and frontal QRS-T angle.

  • Kardiyolojide Güncel Kanıtlarla Vaka Yönetimi

    by Ufuk Aydoğdu, Elif Gökçen Vatanoğlu, Görkem Kuş, Murat Demirci, Vedat Aslan, Hatice İrEm Üzümcü, Semih Kalkan, Oğuz Kaan Kaya, Ahmet Genç, Orhan İnCe, et al.

  • Heart Rate Variability in Hospitalized Patients with Suspected or Confirmed Diagnosis of COVID-19: A Retrospective Analysis in Comparison to Healthy Controls and in Relation to Proinflammatory Cytokines

    by Dursun Topal, Berat Uğuz, İsMet Zengi̇n, Selvi Coşar, Selma Ti̇rYaki̇oĞlu

    Objective: This study was designed to evaluate heart rate variability (HRV) in hospitalized patients with suspected or confirmed diagnosis of coronavirus disease-2019 (COVID-19) in comparison to healthy controls and in relation to proinflammatory cytokines. Materials and Methods: A total of 115 subjects consisting of 3 subgroups (53 patients with confirmed diagnosis of COVID-19, 42 patients with suspected diagnosis of COVID-19 and 20 healthy controls) were included in this study. Data on patient demographics, inflammatory markers (C-reactive protein [CRP], D-Dimer, ferritin, procalcitonin) and the 24-h Holter monitoring parameters were recorded. Results: None of the Holter monitoring parameters differed significantly between patients with suspected COVID-19 and those with confirmed COVID-19. In both suspected COVID-19 and confirmed COVID-19 groups, standard deviation of all NN intervals (SDNN, p


  • Perkütan Koroner Girişimlerde Temel Yaklaşımlar

    by Veysi Can, Mustafa Kınık, İsMet Zengin, Selvi Öztaş, Ahmet Tütüncü, Sencer Çamcı, Tufan Günay, Kübra Severgün, Berat Uğuz

    Andreas Roland Gruentzig tarafından 16 Eylül 1977 tarihinde yapılan ilk anjiyoplastiden bu yana en iyi sonuçları elde etmek için perkütan koroner yaklaşımlar durmaksızın gelişme göstermektedir.Bu kitap kardiyoloji eğitimi devam eden meslektaşlarımıza perkütan koroner girişimlerdeki temel yaklaşımları, bu konudaki en güncel verileri ve teknikleri sunmayı amaçlamaktadır.

  • Open Access

    Effects of exercise-based cardiac rehabilitation on heart rate variability and turbulence in patients with ST elevation myocardial infarction

    by İsMet Zengin, Selma Arı, Hasan Arı, Mehmet Melek

    Objectives: The objective of this study was to evaluate the effect of the exercise-based cardiac rehabilitation (CR) on the heart rate variability (HRV) and turbulence (HRT) in patients with ST elevation myocardial infarction (STEMI) treated with the primary percutaneous coronary intervention (PCI).Methods: One hundred one patients with STEMI, who underwent primary PCI were included in our study. Sixty-eight of these patients were randomized to the CR group and the remaining 33 patients to the control group. One month after the primary PCI, cardiac rehabilitation was performed in CR group with a cycle ergometer for 8 weeks (30 sessions). One month after STEMI, rhythm Holter monitorization was carried out in both groups for 48 hours. The rhythm Holter monitorization was repeated in cardiac rehabilitation group (CR group) after the cardiac rehabilitation again for 48 hours. HRV was evaluated according to time and frequency domains; HRT was evaluated with the turbulence onset and turbulence slope parameters obtained from the Holter recordings.Results: Baseline characteristics and baseline HRV and HRT parameters were comparable between CR group and control group. In CR group, there was no statistically significant difference between the HRV and HRT parameters, which were obtained before and after the cardiac rehabilitation. The subgroup analyses (left ventricular ejection fraction lower or higher than 40%) showed that turbulence onset improved with the cardiac rehabilitation in the group with an ejection fraction lower than 40%. Conclusions: Our results showed that exercise-based cardiac rehabilitation did not affect HRV and HRT in patients whose left ventricular ejection fraction was mildly affected (> 40%) after the treatment with primary PCI. However, the cardiac rehabilitation provided an improvement of turbulence onset in patients with the low left ventricular ejection fraction.